Regenerative Sciences Inc. is focused on the development of Regenexx™, a breakthrough non-surgical option for people suffering from various orthopedic disorders. They have developed a patent-pending procedure that uses a person’s own stem cells and blood growth factors to regenerate bone and cartilage. The physicians at RSI are dedicated to providing the option of non-surgical joint repair to patients.

Headquartered in Colorado, RSI focuses on delivering high-quality treatment for people suffering from these often-debilitating diseases.

RSI believes in educating patients, providing choices, offering options and encouraging people to take an active role in their own treatment. RSI strives to improve the quality of life for each patient through compassion, dedication and innovative treatment plans designed to meet the individual needs of the patient.

Regenerative Sciences, Inc. was formed as a Colorado-based LLC on Jan. 1, 2006. Executive Management includes:

Christopher Centeno, M.D. - Founder, Inventor and Medical Director

Carl Measer, MBA - Chief Operations Officer

John Schultz, M.D. - Researcher

John Kisiday, Ph.D. - Researcher

Michelle Cheever - Lab Director

403 Summit Blvd., Suite 201
Westminster, CO 80021

www.regenexx.com